Why has BAVI had remarkably similar results in
1.different genotypes(Georgia and India)?
2.different cancers(breast and lung)?
3.different combinations(docetaxol,paclitaxol and carboplatin)?
Isn't this part of BAVI's strength because it TARGETS PS and awakens the immune system to work IN VIRTUALLY ALL GENOTYPES,AGAINST VIRTUALLY ALL CANCERS, and with VIRTUALLY ALL CHEMOTHERAPIES AND IRRADIATION.
It seems to me to be similar to the way it goes after ALL ENVELOPED VIRUSES because it is targeting PS and NOT the frequently changing virus itself! Just as it is a broad spectrum anti-viral it is a broad spectrum anti-cancer agent!
And what is really exciting is that while it is effective as a naked MAb it has ,IMHO, even greater potential as an armed MAb. Armed it can take a cancer or virus killing payload right to the cancer or viral site and overcome the safety and side-effect problems of current treatments.